Search

Your search keyword '"Entamoebiasis drug therapy"' showing total 249 results

Search Constraints

Start Over You searched for: Descriptor "Entamoebiasis drug therapy" Remove constraint Descriptor: "Entamoebiasis drug therapy"
249 results on '"Entamoebiasis drug therapy"'

Search Results

151. Cutaneous amebiasis in children.

152. Amebiasis and "nonpathogenic" intestinal protozoa.

153. Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment.

155. [Amebic brain abscess. Apropos of a case].

157. Amebiasis.

158. Isolation of Entamoeba histolytica from arthritic knee joint.

159. Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States.

160. [A case of focal necrotizing granulomatous hepatitis in childhood].

161. [Diphetarsone-induced hepatitis. A second case].

162. Luminal agents in the treatment of amebiasis.

163. [Entamoeba histolytica: a standing threat].

164. Amebiasis.

165. [Amebiasis].

166. [3 cases of hematogenous lung abscess of amebic origin].

167. Atrial septal defect presenting as recurrent primary amoebic lung abscess.

168. Intestinal parasites in Cambodians: comparison of diagnostic methods used in screening refugees with implications for treatment of populations with high rates of infestation.

169. Entamoeba histolytica infections in flight personnel of an international airline.

170. Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya.

171. Management of pregnant women with diarrhoea at term and of healthy carriers of infectious agents in stools at delivery.

172. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs.

173. [Treatment of amibiasis with short-term secnidazole therapy].

174. Diagnosis and treatment of five parasites. Enterobius vermicularis, Giardia lamblia, Trichuris trichiura, Ascaris lumbricoides, Entamoeba histolytica.

175. Angioedema due to diphetarsone and a review of its toxicity.

176. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.

177. Entamoeba polecki infection in Southeast Asian refugees: multiple cases of a rarely reported parasite.

178. [Strategies for improving the therapeutic patterns in acute diarrhea in primary medical care units. V. Evaluation of a therapeutic regimen based exclusively on clinical data].

179. Safety and efficacy of diphetarsone in the treatment of amoebiasis, non-pathogenic amoebiasis and trichuriasis.

182. Bisamidines of 2,6-diaminoanthraquinone as antiamebic agents.

183. An unusual cutaneous amoebic ulcer.

184. Epizootic of fatal amebiasis among exhibited snakes: epidemiologic, pathologic, and chemotherapeutic considerations.

185. Successful treatment of symptomatic Entamoeba polecki infection.

186. [Amebiasis. Medical treatment. Is there anything better than metronidazole?].

187. Chemotherapeutically active nitro compounds. 4. 5-Nitroimidazoles (Part I).

188. Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects.

189. The aetiology, diagnosis and treatment of amoebic disease.

190. Experimental amoebiasis and the development of anti-amoebic compounds.

191. Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.

192. Gastrointestinal parasites: Part I. Protozoal infections.

193. 1,4-Bis-[1-methyl-5-nitroimidazolyl-(2-methyleneimino)]-piperazine, a new drug with marked activity against Entamoeba histolytica. Short communication.

194. Treatment of intestinal parasites in Australian aboriginal children.

195. [Contramibial. Importance in amebiasis and other protozoosis].

196. Amebiasis.

197. Chemotherapeutically active anthraquinones. I. Aminoanthraquinones.

199. [Diarrhea caused by parasites].

200. Amoebiasis and its control.

Catalog

Books, media, physical & digital resources